2,3-Butanedione 2-monoxime (BDM) induces calcium release from canine cardiac sarcoplasmic reticulum

Biochemical and Biophysical Research Communications
R M Phillips, R A Altschuld

Abstract

2,3-Butanedione 2-monoxime (BDM) is a well known inhibitor of skeletal and cardiac muscle contraction. Recently, it has been discovered that BDM has an influence on the sarcoplasmic reticulum (SR). We investigated the effects of BDM on the SR in our digitonin lysed myocyte system, which measures accumulated SR Ca2+. While BDM (30 mM) had no effect on SR Ca2+ uptake (under conditions that included Ca2+ release channel efflux inhibitors), it induced SR Ca2+ release (no efflux inhibitors) with a maximal reduction of 72% of SR Ca2+ at pCa 6.0. A titration showed that even 5 mM BDM resulted in a 45% reduction at that same pCa. Also, a positive correlation was found between the degree of BDM induced Ca2+ release and free Ca2+ concentration. Thus, the use of even low concentrations of BDM as an excitation-contraction uncoupler must be approached with caution.

Citations

Nov 16, 2004·The Japanese Journal of Physiology·M Takaki
Jun 29, 1999·European Journal of Cell Biology·L M BlackmanR L Overall
Feb 4, 1999·European Journal of Cell Biology·G Steinberg, J R McIntosh
Nov 30, 2006·Annals of the New York Academy of Sciences·Henk E D J ter KeursBruno D M Stuyvers
May 17, 2006·Acta Biomaterialia·Arne Schäfer, Manfred Radmacher
Feb 28, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Daisuke YamashitaMiyako Takaki
Sep 16, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Danielle F FelicianoJosé W M Bassani
Sep 29, 2000·American Journal of Physiology. Heart and Circulatory Physiology·R C Scaduto, L W Grotyohann
Mar 27, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Callum M JohnstonAndrew J Taberner
Nov 30, 2010·Protoplasma·Janine E Radford, Rosemary G White

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.